Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Premium Statistic Biotech projects on medicines in development in Spain 2023, by therapeutic area
- Premium Statistic Diagnostics and personalized medicine projects in Spain 2023, by therapeutic area
- Premium Statistic R&D expenditure of new therapeutic drugs 2009-2018
- Premium Statistic Clinical trial success rates by therapeutic area 2020
- Basic Statistic Percent of registered clinical studies worldwide by location 2024
- Basic Statistic Share of recruiting clinical studies worldwide by location 2024
- Basic Statistic Percent of registered clinical studies worldwide by type 2024
- Premium Statistic Total number of registered clinical studies worldwide 2000-2024
- Basic Statistic Number of registered clinical studies by location worldwide 2024
About the region
10
- Basic Statistic Comparison between the complexity of clinical trials 2001-2015
- Basic Statistic Increase in clinical trials' complexity 2001-2015
- Basic Statistic Estimated clinical trial cost per patient by therapeutic class 2015-2017
- Basic Statistic Estimated clinical trial cost per drug by therapeutic class 2015-2017
- Premium Statistic Time from R&D start to approval of select cancer drugs 2017
- Premium Statistic Total R&D costs of select cancer drugs 2017
- Premium Statistic Total R&D costs including costs of capital for select cancer drugs 2017
- Basic Statistic Total per-study costs by clinical trial phase and therapeutic area
- Basic Statistic Clinical trial costs by select component and phase
- Basic Statistic Average per-study costs by trial phase
Selected statistics
6
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2023
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
Other regions
10
- Basic Statistic Total number of registered clinical studies with posted results worldwide 2008-2024
- Basic Statistic Biologic medicines sales distribution by treatment costs in Canada 2018
- Basic Statistic Usage of infliximab biosimilars in select countries 2018
- Basic Statistic Roche Group's net income 2007-2023
- Basic Statistic Largest pharmaceutical classes in Sweden 2022, by sales value
- Premium Statistic Novartis' sales revenue in Spain 2012-2020
- Premium Statistic Pharmaceutical market size in China 2016-2022
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
Related statistics
10
- Premium Statistic Unsuccessful attempts and new drugs for cancer types 1998-2014
- Premium Statistic Revenue as a part of R&D spending for select cancer drugs 2017
- Basic Statistic Market share of clinical trials worldwide by segment
- Basic Statistic Investments made by clinical research organizations by phase 2009-2014
- Basic Statistic Percent of clinical studies with posted results worldwide by type 2024
- Premium Statistic World pharmaceutical market: changes in revenue by region 2022
- Basic Statistic Select prescription drug price percent changes in the US 2010-2017
- Basic Statistic Drugs in development with potential to be first-in-class in 2016, by therapeutic area
- Premium Statistic Prescription drug price development in the U.S. by select drug 2010-2017
- Premium Statistic Revenue since approval for select cancer drugs 2017
Further related statistics
10
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co - expenditure on research and development 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- GSK's operating profit by division 2006-2021
- Global pharmaceutical pipeline by therapy area 2013-2017
Further Content: You might find this interesting as well
Statistics
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Merck & Co - expenditure on research and development 2006-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- AstraZeneca's expenditure on research and development 2006-2023
- CVS Health's total assets 2005-2023
- GSK's operating profit by division 2006-2021
- Global pharmaceutical pipeline by therapy area 2013-2017
PhRMA. (December 15, 2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*." Chart. December 15, 2020. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. (2020). Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category*. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA. "Number of Biopharma Medicines in Development in The U.S. as of April 2020, by Select Therapeutic Category*." Statista, Statista Inc., 15 Dec 2020, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/
PhRMA, Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* Statista, https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/ (last visited June 01, 2024)
Number of biopharma medicines in development in the U.S. as of April 2020, by select therapeutic category* [Graph], PhRMA, December 15, 2020. [Online]. Available: https://www.statista.com/statistics/258152/biologic-medicines-in-development-by-therapeutic-category-2016/